SAR245409 XL765 Voxtalisib PI3K Inhibitors Cas 1349796-36-6
| Size | Price | Stock | Quantity |
|---|---|---|---|
| Get Quotation Now Add to Cart Bulk Inquiry | |||
| Product name:XL765 Voxtalisib | Purity:98% min |
| CAS NO:1349796-36-6 | Solubility:DMSO27.5 mg/mL (45.86 mM) |
| Molecular Formula:C31H29N5O6S | Package:Package according to customer requirements |
| Molecular Weight:599.657 | Storage:Store at -20℃ |
Voxtalisib, also known as XL-765 and SAR245409, is a PI3K/mTOR dual kinase inhibitor XL765 is an orally bioavailable small molecule targeting the phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) kinases in the PI3K/mTOR signaling pathway, with potential antineoplastic activity. PI3K/mTOR dual kinase inhibitor XL765 inhibits both PI3K kinase and mTOR kinase, which may result in tumor cell apoptosis and growth inhibition in susceptible tumor cell populations.
Related Products:
PKI-402; Pilaralisib; PI-3065; VS-5584; PIK-294; AZD6482; GSK1059615; AZD8186; CUDC-907; AZD8835; AMG319; Buparlisib hydrochloride; Umbralisib; PIK-III; VPS34-IN1; VPS34 inhibitor 1; Wortmannin
Get in Touch
Have questions about our products or want to discuss a custom order? Our team is ready to help you.